TPH2 and astrocytoma (excluding glioblastoma): Further, treatment of human brain glioblastoma/astrocytoma (U87 MG) cells with 1,25(OH)D, the active metabolite of vitamin D, was found to significantly increase TPH2 mRNA in a dose-dependent manner [19].